227 related articles for article (PubMed ID: 12126946)
1. Spinocerebellar ataxia type 7 (SCA7) shows a cone-rod dystrophy phenotype.
Aleman TS; Cideciyan AV; Volpe NJ; Stevanin G; Brice A; Jacobson SG
Exp Eye Res; 2002 Jun; 74(6):737-45. PubMed ID: 12126946
[TBL] [Abstract][Full Text] [Related]
2. Interference of Crx-dependent transcription by ataxin-7 involves interaction between the glutamine regions and requires the ataxin-7 carboxy-terminal region for nuclear localization.
Chen S; Peng GH; Wang X; Smith AC; Grote SK; Sopher BL; La Spada AR
Hum Mol Genet; 2004 Jan; 13(1):53-67. PubMed ID: 14613968
[TBL] [Abstract][Full Text] [Related]
3. Somatic instability of expanded CAG repeats of ATXN7 in Japanese patients with spinocerebellar ataxia type 7.
Katagiri S; Hayashi T; Takeuchi T; Yamada H; Gekka T; Kawabe K; Kurita A; Tsuneoka H
Doc Ophthalmol; 2015 Jun; 130(3):189-95. PubMed ID: 25643591
[TBL] [Abstract][Full Text] [Related]
4. A Proposal for Classification of Retinal Degeneration in Spinocerebellar Ataxia Type 7.
Marianelli BF; Filho FMR; Salles MV; de Andrade JBC; Pedroso JL; Sallum JMF; Barsottini OGP
Cerebellum; 2021 Jun; 20(3):384-391. PubMed ID: 33196954
[TBL] [Abstract][Full Text] [Related]
5. Polyglutamine-expanded ataxin-7 antagonizes CRX function and induces cone-rod dystrophy in a mouse model of SCA7.
La Spada AR; Fu YH; Sopher BL; Libby RT; Wang X; Li LY; Einum DD; Huang J; Possin DE; Smith AC; Martinez RA; Koszdin KL; Treuting PM; Ware CB; Hurley JB; Ptácek LJ; Chen S
Neuron; 2001 Sep; 31(6):913-27. PubMed ID: 11580893
[TBL] [Abstract][Full Text] [Related]
6. Antisense oligonucleotides targeting mutant Ataxin-7 restore visual function in a mouse model of spinocerebellar ataxia type 7.
Niu C; Prakash TP; Kim A; Quach JL; Huryn LA; Yang Y; Lopez E; Jazayeri A; Hung G; Sopher BL; Brooks BP; Swayze EE; Bennett CF; La Spada AR
Sci Transl Med; 2018 Oct; 10(465):. PubMed ID: 30381411
[TBL] [Abstract][Full Text] [Related]
7. Genotype-phenotype correlation in a German family with a novel complex CRX mutation extending the open reading frame.
Paunescu K; Preising MN; Janke B; Wissinger B; Lorenz B
Ophthalmology; 2007 Jul; 114(7):1348-1357.e1. PubMed ID: 17320181
[TBL] [Abstract][Full Text] [Related]
8. SCA7 knockin mice model human SCA7 and reveal gradual accumulation of mutant ataxin-7 in neurons and abnormalities in short-term plasticity.
Yoo SY; Pennesi ME; Weeber EJ; Xu B; Atkinson R; Chen S; Armstrong DL; Wu SM; Sweatt JD; Zoghbi HY
Neuron; 2003 Feb; 37(3):383-401. PubMed ID: 12575948
[TBL] [Abstract][Full Text] [Related]
9. Polyglutamine-expanded ataxin-7 inhibits STAGA histone acetyltransferase activity to produce retinal degeneration.
Palhan VB; Chen S; Peng GH; Tjernberg A; Gamper AM; Fan Y; Chait BT; La Spada AR; Roeder RG
Proc Natl Acad Sci U S A; 2005 Jun; 102(24):8472-7. PubMed ID: 15932940
[TBL] [Abstract][Full Text] [Related]
10. Retinal degenerations with truncation mutations in the cone-rod homeobox (CRX) gene.
Jacobson SG; Cideciyan AV; Huang Y; Hanna DB; Freund CL; Affatigato LM; Carr RE; Zack DJ; Stone EM; McInnes RR
Invest Ophthalmol Vis Sci; 1998 Nov; 39(12):2417-26. PubMed ID: 9804150
[TBL] [Abstract][Full Text] [Related]
11. RNA interference-based therapy for spinocerebellar ataxia type 7 retinal degeneration.
Ramachandran PS; Bhattarai S; Singh P; Boudreau RL; Thompson S; Laspada AR; Drack AV; Davidson BL
PLoS One; 2014; 9(4):e95362. PubMed ID: 24759684
[TBL] [Abstract][Full Text] [Related]
12. Clinical characterization and the improved molecular diagnosis of autosomal dominant cone-rod dystrophy in patients with SCA7.
Zou X; Yao F; Li F; Wu S; Li H; Sun Z; Zhu T; Wei X; Li D; Sui R
Mol Vis; 2021; 27():221-232. PubMed ID: 34012225
[TBL] [Abstract][Full Text] [Related]
13. Macular dysfunction and morphology in spinocerebellar ataxia type 7 (SCA 7).
Hugosson T; Gränse L; Ponjavic V; Andréasson S
Ophthalmic Genet; 2009 Mar; 30(1):1-6. PubMed ID: 19172503
[TBL] [Abstract][Full Text] [Related]
14. Spinocerebellar ataxia type 7 (SCA7) - correlations between phenotype and genotype in one large Belgian family.
Martin J; Van Regemorter N; Del-Favero J; Löfgren A; Van Broeckhoven C
J Neurol Sci; 1999 Sep; 168(1):37-46. PubMed ID: 10500272
[TBL] [Abstract][Full Text] [Related]
15. Electrophysiologic and phenotypic features of an autosomal cone-rod dystrophy caused by a novel CRX mutation.
Lines MA; Hébert M; McTaggart KE; Flynn SJ; Tennant MT; MacDonald IM
Ophthalmology; 2002 Oct; 109(10):1862-70. PubMed ID: 12359607
[TBL] [Abstract][Full Text] [Related]
16. Human retinal disease from AIPL1 gene mutations: foveal cone loss with minimal macular photoreceptors and rod function remaining.
Jacobson SG; Cideciyan AV; Aleman TS; Sumaroka A; Roman AJ; Swider M; Schwartz SB; Banin E; Stone EM
Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):70-9. PubMed ID: 20702822
[TBL] [Abstract][Full Text] [Related]
17. Spinocerebellar ataxia type 7 associated with pigmentary retinal dystrophy.
Michalik A; Martin JJ; Van Broeckhoven C
Eur J Hum Genet; 2004 Jan; 12(1):2-15. PubMed ID: 14571264
[TBL] [Abstract][Full Text] [Related]
18. Spinocerebellar ataxia type 7 with
Park JY; Wy SY; Joo K; Woo SJ
Ophthalmic Genet; 2019 Jun; 40(3):282-285. PubMed ID: 31269856
[No Abstract] [Full Text] [Related]
19. Disease progression despite early loss of polyglutamine protein expression in SCA7 mouse model.
Helmlinger D; Abou-Sleymane G; Yvert G; Rousseau S; Weber C; Trottier Y; Mandel JL; Devys D
J Neurosci; 2004 Feb; 24(8):1881-7. PubMed ID: 14985428
[TBL] [Abstract][Full Text] [Related]
20. Molecular pathogenesis and cellular pathology of spinocerebellar ataxia type 7 neurodegeneration.
Garden GA; La Spada AR
Cerebellum; 2008; 7(2):138-49. PubMed ID: 18418675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
